Management of Antiphospholipid Syndrome
Antiphospholipid syndrome (APS), is an acquired autoimmune disorder characterised by thrombosis, pregnancy morbidity, and the presence of antiphospholipid antibodies (aPL). Although venous thromboembolism is the most common manifestation, thrombotic events in APS may also occur in virtually any vasc...
Main Authors: | Amine Ghembaza, David Saadoun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/11/508 |
Similar Items
-
Direct-acting oral anticoagulants in antiphospholipid syndrome
by: T. M. Reshetnyak, et al.
Published: (2021-01-01) -
Antiphospholipid Syndrome Novel Therapies
by: Mohamad Bittar, et al.
Published: (2014-07-01) -
Antiphospholipid Syndrome
by: Thaís da Silva Santos, et al.
Published: (2019-11-01) -
Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study
by: Yu Song, et al.
Published: (2017-01-01) -
Fetal Intraventricular Hemorrhage Due to Antiphospholipid Syndrome: A Case Report
by: M. C. Bouw, et al.
Published: (2021-02-01)